Federal officials and health care executives rubbed elbows at the ritzy MAHA Summit, causing some supporters to question what MAHA has become.

Blockbuster GLP-1 drugs have transformed the lives of millions of people. Lately, they’re undergoing a makeover of their own.

The GOP bill directs MedPAC to study the topic of overpayments to Medicare Advantage plans in a manner that’s more favorable to insurers.

Firms are spending hundreds of millions of dollars to convince doctors to prescribe GLP-1 drugs.

The legal basis for the $500 checks, and who would get them, isn't entirely clear.

Katherine Clark, a top House Democrat, received more than $100,000 in campaign donations from people linked to UnitedHealth Group.

New $24.99 monthly plan includes a primary member and up to four dependents, including children, adults, and pets, with more than 250 generic medications available for free and savings on dental, vision, lab and imaging services Brief Summary: GoodRx launched the Companion Family Plan for $24.99

Politicians are contemplating raising taxes and cutting benefits as the cost of health care for government workers surges.

We examine a call to reform how health insurers do business, and a look at the impact of 340B restrictions.

Doctors are asking how to get retatrutide for their patients, after Eli Lilly gave one man early access.

A new survey reveals 24% of U.S. workers stay in unwanted jobs to keep health insurance. Experts call it 'job lock.'

Office Hours with STAT's Bob Herman: Join us at 1 p.m. EST July 22 to learn more about his series on the soaring costs of employer-based health insurance.

Insurance giant UnitedHealth signals the cost of providing workers with health insurance will climb even higher.

Demand for alcohol is declining. The industry is fighting harder and more creatively than ever against limits — and winning.

The hospital operator Nutex enriched itself by exploiting loopholes in laws meant to protect patients, STAT found.

Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental obesity drug through the agency’s “compassionate use” program.

“Government has to intervene, because healthcare is run like an unregulated utility,” Indiana’s GOP governor says of the state’s effort to regulate hospital prices.

Congenital syphilis should be preventable. An Arizona case shows how drug shortages and procedural hurdles are fueling a growing public health crisis.

None of STAT's requests for Kennedy's schedule have been completed, and some haven't even been acknowledged.

Federal investigation finds Medicare Advantage insurers block rehab care for older adults, only to reverse denials on appeal.

State AG alleges UnitedHealthcare claimed some members were sicker to boost its profits.

Jeffery Taubenberger, the acting head of the NIAID, the NIH’s infectious disease institute, is reported to have stepped down.

More than 1 in 8 pregnant women report drinking. Doctors warn fetal alcohol disorders may be more common than many realize, perhaps more common than autism.

New ethics disclosures show the president invested in Eli Lilly and a company that manufactures injectable devices as his health agencies implemented policies that benefited them.

What was lost at the FDA: A year after DOGE’s cuts, six agency staffers describe the work they never thought they’d leave.

Sanofi has asked the FDA to pull its type 1 diabetes drug out of Commissioner Marty Makary’s new speedy drug review program.

ACA membership is tumbling after Congress failed to extend extra subsidies that helped people afford the coverage.

The thinking about what risk Covid poses — or doesn't pose — has shifted in recent years. What does it mean for you?

Pharma industry middlemen are pushing back on a major drug price transparency proposal.

The stocks of major Medicare Advantage insurers surged on the announcement.

CMS is scaling back the number of measures it uses to grade health insurers.

STAT investigates how a Texas couple cashed in on a new law that's supposed to protect patients from surprise medical bills.

Breaking: A federal judge on Monday stalled major parts of health secretary Robert F. Kennedy Jr.’s campaign to remake vaccine policy in the U.S.